Deconstructing Polypharmacy. Alan B. Douglass, M.D. Director

Similar documents
If a bad thing is happening to a patient, a drug did it until proven otherwise

MEDICATION APPROPRIATENESS FOR THE AGING POPULATION. Building Partnerships for Successful Aging

Polypharmacy & De-prescribing In Older Adults

DEPRESCRIBING IN THE ELDERLY

Deprescribing Unnecessary Medications: A Four-Part Process

Polypharmacy and the Older Adult. Leslie Baker, PharmD, BCGP Umanga Sharma, MD

STOPP and START criteria October 2011

PRESCRIBING IN THE ELDERLY. CARE HOME PHARMACY TEAM Bhavini Shah, Eleesha Pentiah & Puja Vyas

1/21/2016 UPDATE ON THE AMERICAN GERIATRICS SOCIETY 2015 BEERS CRITERIA DISCLOSURE OBJECTIVES AGING GOALS BEERS CRITERIA

START, STOPP, Beers Oh My! Navigating the World of Geriatric Pharmacy

Polypharmacy and Elders. Leslie Baker, Pharm. D., RPh, CGP Sanford Center for Aging

Geriatric Pharmacology

STOPP START Toolkit Supporting Medication Review in the Older Person

POLYPHARMACY IN OLDER ADULTS AND BEERS CRITERIA UPDATE

Danielle Pierotti RN, PhD, AOCN, CHPN Chief Nurse/Director of Clinical Practice HCI Hospice. with you at every step

Taking the harm out of Polypharmacy Step by step. Karen Reid and Claire Stein Lead Integrated Care Pharmacist NHS Lothian

Medication Use in Older Adults

< = > less is more. De-diagnosing De-prescribing Non-testing

Appropriate prescribing and deprescribing for older people getting it right. Alan Davis Northland District Health Board

Maximizing Medication Safety UNIVERSITY OF HAWAII AUGUST 31, 2016

ESPEN Congress The Hague 2017

Geri-PARDY! (2015 Beers Criteria) Pharmacology Edition

Disclosures. Use caution in the elderly: review of safe and effective medication use in older patients. Institute of Medicine. Learning Objectives

A C A D E M I C D E TA I L I N G C H O O S I N G W I S E LY C O N F E R E N C E O C T 2 1, PA M M C L E A N - V E Y S E Y B S C P H A R M D R

Meds and Falls: Keep in Step with your Meds

Katee Kindler, PharmD, BCACP

Objectives. Case Ruby. 1- Warfarin. 1- Warfarin. Warfarin discontinuation 8/13/ DRUGS TO STOP GIVING HOSPICE PATIENTS

BLCS 1-Clinical Overview. Dr. Chris Rauscher Clinical Lead Shared Care Polypharmacy Risk Reduction Initiative

Medicines save lives

Rebecca Rottman-Sagebiel, Pharm.D., BCPS Sharon Jung Tschirhart, Pharm.D., BCPS Geriatric Clinical Pharmacy Specialists STVHCS, Audie L.

Pharmaceutical Care for Geriatrics

Pharmacology in the Elderly

Adjusting and Withdrawing Medications in the Elderly

Mucky Meds: A (practical) approach the nightmare med list. Michelle Gibson, MD, CCFP (COE), FCFP and Erin Beattie, MD, CCFP

A Primer on Safe Prescribing to the Elderly. Dr. John Puxty

Interdisciplinary detection of potential drug related problems in older people

TOP 5 DRUGS.. TO AVOID IN THE ELDERLY

Transitions of Care & Medication Reconciliation Ashley King, PharmD, BCGP Clinical Pharmacist LECOM Health March 2018

University of Hawaii Center on Aging

From MCI to Dementia DR YU- MIN LIN GERIATRICIAN AUG 2018

Appropriateness of prescribing in older patients

Medication Reviews within Care Homes. Catherine Armstrong

A Step Forward: Promoting Independence through Falls Prevention

There s A Pill For That (But should my patient be on it?) A Review of Tools for the Evaluation of Optimal Prescribing in Geriatric Patients

Presented by: Ontario s Geriatric Steering Committee

De-prescribing in Older Adults. Wael Hamade, MD, FAAFP 04/08/2016

HA CONVENTION Effectiveness of Pharmacist-led Frail Elderly Medication Service in Acute Geriatric Ward

Screening tools for elderly patients in primary care

Management of DM in Older Adults: It s not all about sugar! Who needs treatment for DM? Peggy Odegard, Pharm.D., BCPS, CDE

Pitfalls in Pharmacotherapy of Geriatrics

Polypharmacy. A CPPE distance learning programme

COMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK

Deprescribing in CKD patients: Is less more? Speaker: Dr. Judith G. Marin, PharmD

Reviewing Medicines in at risk patients care homes

Diabetes and the Elderly: Medication Considerations When Determining Benefits and Risks

Rationalizing Medications. Tan Jianming Senior Pharmacist KTPH

Anthony J. Caprio, MD, CMD, AGSF 1

Polypharmacy, Medication Nihilism, and the art of de-prescribing

2/11/2016. Managing Polypharmacy: Evidence-based Dissection of Pharmaceuticals. Disclosure. Objectives

Polypharmacy and Polymorbid Patients: Practical Tips and Tricks

Strategies to Decrease Medication Errors in Elderly. Abeer Zeitoun, Pharm. D Certified in Medication Safety, MCPHS

Shared decision making for stepdown and stopping decisions. Michael R. Gionfriddo Pharm.D, Ph.D Geisinger Center for Pharmacy Innovation and Outcomes

1/16/2018. Disclosure Information. Objectives. Geriatric Scalpel: Improving Lives of Older Adults Through Rational Deprescribing

Amal AL-Anazi, BSc.(Pharm) Medication Safety Officer In Eastern Region

Jennifer Loh, MD, FACE Chief of Endocrinology KP Hawaii AAMD of Medical Education, KP Hawaii

OBJECTIVES. Key issues in geriatric pharmacology. Effects of age on pharmacokinetics and pharmacodynamics

Special thanks to the EJC Foundation for their support of Sanford Center Geriatric Specialty Clinic

Polypharmacy and Deprescribing for Older People

Polypharmacy. Polypharmacy. Suboptimal Prescribing in Older Adults. Kenneth Schmader, MD Professor of Medicine-Geriatrics

Use caution in the elderly: review of safe and effective medication use in older patients

Optimising Safe & Appropriate Medicines Use and Deprescribing. Katie Smith, Director, East Anglia Medicines Information Service February 2014

Let it go! Rationalising medicines for patients with life limiting illness

Polypharmacy in the Elderly

ASPIRIN MISUSE AT HOME ACCORDING TO START AND STOPP IN FRAIL OLDER PERSONS

ENSURING EXCELLENCE IN PRESCRIBING FOR OLDER ADULTS

AGS Annual Meeting May Sponsored by the Polypharmacy Special Interest Group and the Pharmacists Section

Review of Current Literature 4/2/18 POLYPHARMACY IN ASSISTED LIVING EVIDENCE BASED APPROACH

Polypharmacy: Guidance for Prescribing in Frail Adults

Optimizing medication in caring for seniors living with frailty: Five perspectives

Medications Contributing to Falls. Kate Niemann, PharmD BCGP AuBurn Pharmacy

Polypharmacy is common among older adults due to

Tackling inappropriate polypharmacy in NHS Scotland

Polypharmacy: Making it all Work Kathy Wilson, RPh, RWSIR Director of Pharmacy

Optimising prescribing in primary care in the face of multimorbidity and polypharmacy

Rational prescribing in the older adult. Assoc Prof Craig Whitehead

Intelligent Polypharmacy. Professor Colin P Bradley Department of General Practice University College Cork

Delving into Deprescription. Todd C. Lee MD MPH FRCPC Associate Professor of Medicine, McGill University With thanks to Dr. Emily G.

About ISMP Canada. Analysis Outputs: Safety Bulletins. Less is More: An Introduction to Deprescribing. canada.org

Preventing Medication Related Falls

Transforming Care for the Elderly

quoted South Park in a talk

Polypharmacy. in the Elderly. Lesley Charles, MBChB, CCFP

Polypharmacy in HIV and Aging. Aroonsiri Sangarlangkarn, MD, MPH, Jonathan S. Appelbaum, MD, FACP

PHARMACOTHERAPY IN THE OLDER PERSON NAMIRAH JAMSHED M.B;B.S ASSOCIATE PROFESSOR UTSW MEDICAL CENTER DALLAS

Identifying Inappropriate Medications and Deprescribing Strategies ANGELA M. HILL, PHARM.D., RCPH GWEP JUNE 9, 2017

The Happy Medium. Principles of Appropriate Prescribing Across the Aging Spectrum Milta Oyola Little, DO, CMD

Stronger together - optimizing pharmacotherapy on geriatric wards?

Family Medicine for English language students of Medical University of Lodz. Seminar 12. Elderly care. Przemysław Kardas MD PhD

DEPRESCRIBING. Phil St John CSIM Workshop

Transcription:

Deconstructing Polypharmacy Alan B. Douglass, M.D. Director

Recognize this patient?

Mrs. Brown- 82 years young Active Medical Problems Hypertension Hyperlipidemia Type 2 Diabetes Peripheral edema Osteoarthritis Urinary incontinence Constipation Dementia Medication List Lisinopril 20 mg daily Furosemide 40 mg daily Aspirin 325 mg daily Lantus 60 units daily Pantoprazole 20 mg daily Atorvastatin 80 mg daily Oxybutynin 5 mg twice daily Risperidone 1mg twice daily Naproxen 500 mg twice daily Metformin 1000 mg twice daily Glipizide 10 mg daily Mirtazapine 30 mg at bedtime Omeprazole 40 mg daily Amlodipine 10 mg daily

Your reactions?

Why does polypharmacy matter?

Definitions Polymedication Prescription of multiple medications to treat multiple conditions Not in and of itself a bad thing Creates risk for polypharmacy Polypharmacy Prescription of unnecessary medication Often the result of poor communication or a prescribing cascade A significant problem

Scope of the Problem U.S. seniors are 13% of population but use 40% of all medication Number of medications prescribed per person has doubled in 20 years 67% of community dwelling seniors are on 5 or more medications 50% of hospitalized seniors are on 7 or more medications 50% of frail seniors are on 9 or more medications 50% of seniors combine prescription with OTC medications 50% of seniors take at least one unnecessary medication Polypharmacy is a significant contributor to morbidity and mortality Adverse drug events increase linearly with number of medications

At Risk Patients Seniors in general Frail patients- not all are elderly Patients with complex or multiple chronic diseases The chronically mentally ill SNF and Rest Home residents

Physical Consequences Weakness and Falls GI bleeds Impaired cognition Progression of CKD Sleep deprivation Urinary frequency and incontinence Fluid retention Malnutrition Xerostomia Constipation

Class-specific Issues Benzodiazepines- Delerium, Falls Oral Hypoglycemics- Hypoglycemia Statins- Myopathy, weakness NSAIDs- CKD, GI bleeding, Fluid Retention, Hypertension PPIs- Decreased absorption, potential ties to dementia and fractures Anticholinergics- Xerostomia, Constipation Antihypertensives- Falls

Practical Consequences Financial cost Managing refills Complexity of administration Compliance decreases as number of medications increases Medication mix-ups

Deprescribing Intentionally stopping medications or reducing dosages to improve health or reduce side effects The opposite of prescribing Something we should all be considering at every visit Our goal should be shorter medication lists as our patients age

Helpful Tools

AGS Beers Criteria Product of American Geriatrics Society Conceived in 1991 and last updated on best evidence in 2015 Identifies medications at high risk of causing adverse side effects in seniors Used to identify potentially inappropriate medications Not meant to be used punatively or supersede clinical judgement in any particular patient, but sometimes is Not good drug - bad drug but potentially appropriate potentially problematic

STOPP/START CRITERIA Developed to address the limitations of the Beers List More practical and may more accurately predict adverse drug effects Provide explicit, evidence based guidelines organized by organ system STOPP examples: TCAs in Glaucoma Loop diuretic in dependent ankle edema without CHF Diltiazem in NYHA Class III or IV CHF Start examples: Warfarin in chronic AFIB with CHADS score >3 Regular inhaled corticosteroids in moderate persistent Asthma ACE Inhibitor in chronic heart failure

Deprescribing.org Provides valuable evidence-based deprescribing algorithms

How do I start deprescribing?

Step #1- Reconcile the Medication List Perhaps the most important step in the process Don t assume you know what your patient is taking Have patient bring in all pill bottles- prescription and OTC Grouping medications by class can assist in visualizing problems

Step #2- Identify High Risk Medications Benzodiazepines and related agonists Oral Hypoglycemics Proton pump inhibitors NSAIDs Antipsychotics Anticholinergics Diuretics Pay attention to dosing- even if a patient needs a medication they may not need a maximal dose

Step #3- Identify Medications With Limited Efficacy Statins in the elderly Antihypertensives in the elderly Anticholinergics

Step #4- Choose What to Deprescribe Potentially harmful Causing side effects No clear indication No evidence of efficacy Unlikely to provide benefit in the patient s expected lifespan Would take a long time to be of benefit to the patient Does this patient still need this medication?

Step #5- Go- Deprescribe! Not a one time event- a multi-visit process Consider it a PDSA cycle Evaluate the risks and benefits of your decision Deprescribe one or at most two medications at a time If you can t remove a medication consider a dose reduction Re-evaluate regularly- by phone/web and in person

Now let s try it!

Mrs. Brown- 82 years young Active Medical Problems Hypertension Hyperlipidemia Type 2 Diabetes Peripheral edema Osteoarthritis Urinary incontinence Constipation Dementia Medication List Lisinopril 20 mg daily Furosemide 40 mg daily Aspirin 325 mg daily Lantus 60 units daily Pantoprazole 20 mg daily Atorvastatin 80 mg daily Oxybutynin 5 mg twice daily Risperidone 1mg twice daily Naproxen 500 mg twice daily Metformin 1000 mg twice daily Glipizide 10 mg daily Mirtazapine 30 mg at bedtime Omeprazole 40 mg daily Amlodipine 10 mg daily

Mrs. Brown- 82 years young Active Medical Problems Medication List Hypertension Lisinopril 20 mg daily Hyperlipidemia Amlodipine 10 mg daily Type 2 Diabetes Furosemide 40 mg daily Peripheral edema Oxybutynin 5 mg twice daily Osteoarthritis Lantus 60 units daily Urinary incontinence Metformin 1000 mg twice daily Constipation Glipizide 10 mg daily Dementia Atorvastatin 80 mg daily Naproxen 500 mg twice daily Aspirin 325 mg daily Mirtazapine 30 mg at bedtime Risperidone 1mg twice daily Donepezil 10 mg daily Omeprazole 40 mg daily Pantoprazole 20 mg daily

Your reactions?

Take Home Messages Polypharmacy is present in 50% of older or high risk patients There are many physical and practical consequences Become familiar with available tools to identify potentially problematic medications Consider Deprescribing at each visit Reconcile medications Identify potentially problematic medications Deprescribe one at a time after assessing risks and benefits Consider dose reduction if discontinuation is not possible Follow-up

Questions?